Published in Semin Neurol on December 01, 1992
Harlequin Color Change: Neonatal Case Series and Brief Literature Review. AJP Rep (2015) 0.80
Hyperhidrosis: anatomy, pathophysiology and treatment with emphasis on the role of botulinum toxins. Toxins (Basel) (2013) 0.77
Idiopathic Flushing with Dysesthesia: Treatment with the 585nm Pulsed Dye Laser. J Clin Aesthet Dermatol (2015) 0.75
Leg ulcers. J Am Acad Dermatol (1991) 2.74
Acne scarring: a classification system and review of treatment options. J Am Acad Dermatol (2001) 2.33
Human dermal mast cells contain and release tumor necrosis factor alpha, which induces endothelial leukocyte adhesion molecule 1. Proc Natl Acad Sci U S A (1991) 2.11
Treatment of tattoos by Q-switched ruby laser. A dose-response study. Arch Dermatol (1990) 2.01
Selective photothermolysis of cutaneous pigmentation by Q-switched Nd: YAG laser pulses at 1064, 532, and 355 nm. J Invest Dermatol (1989) 1.60
Laser treatment of pigmented lesions--2000: how far have we gone? Arch Dermatol (2000) 1.54
Brief report: graft-versus-host disease associated with transfusion of blood from unrelated HLA-homozygous donors. N Engl J Med (1993) 1.46
Transfusion-associated graft-vs-host disease in patients with malignancies. Report of two cases and review of the literature. Arch Dermatol (1990) 1.42
Facial skin rejuvenation: laser resurfacing or chemical peel: choose your weapon. Dermatol Surg (2001) 1.39
Keloids and hypertrophic scars: review and treatment strategies. Semin Cutan Med Surg (1999) 1.37
Autonomic function and human immunodeficiency virus infection. Neurology (1990) 1.26
Necrobiosis lipoidica. J Am Acad Dermatol (1991) 1.16
The role of lasers and light sources in the treatment of leg veins. Dermatol Surg (1999) 1.11
Prevalence of skin disease in a cohort of shelter-based homeless men. J Am Acad Dermatol (1999) 1.10
Chronic localized herpes zoster in the acquired immunodeficiency syndrome. Arch Dermatol (1990) 1.10
Treatment of minocycline-induced hyperpigmentation with the Q-switched ruby laser. Arch Dermatol (1996) 0.99
Accessibility and reliability of cutaneous laser surgery information on the World Wide Web. J Am Acad Dermatol (2000) 0.98
Disseminated superficial actinic porokeratosis. Coexistence with other porokeratotic variants. Arch Dermatol (1986) 0.93
Release of prostaglandin D2 and histamine in a case of localized heat urticaria, and effect of treatments. Br J Dermatol (1986) 0.92
Serum albumin. Differences in assay specificity. Nutr Clin Pract (1989) 0.91
Birt-Hogg-Dube syndrome: treatment of cutaneous manifestations with laser skin resurfacing. Arch Dermatol (2001) 0.90
Vancomycin-induced linear IgA bullous dermatosis. Arch Dermatol (1988) 0.89
A clinical and histologic prospective controlled comparative study of the picosecond titanium:sapphire (795 nm) laser versus the Q-switched alexandrite (752 nm) laser for removing tattoo pigment. J Am Acad Dermatol (1999) 0.89
Spectral analysis of heart rate in diabetic autonomic neuropathy. A comparison with standard tests of autonomic function. Arch Neurol (1991) 0.88
A histopathological comparison of "char-free" carbon dioxide lasers. Dermatol Surg (1996) 0.88
Recent advances in dermatology. N Engl J Med (1992) 0.88
Basic laser principles. Dermatol Clin (1997) 0.88
Q-switched ruby laser irradiation of normal human skin. Histologic and ultrastructural findings. Arch Dermatol (1991) 0.87
On beauty: evolution, psychosocial considerations, and surgical enhancement. Arch Dermatol (2001) 0.86
Melanosomes are a primary target of Q-switched ruby laser irradiation in guinea pig skin. J Invest Dermatol (1987) 0.86
Cutaneous polyarteritis nodosa associated with hepatitis B surface antigen. J Am Acad Dermatol (1986) 0.86
Fractional Laser treatment for pigmentation and texture improvement. Skin Therapy Lett (2006) 0.85
Laser therapy versus cryotherapy of lentigines: a comparative trial. J Am Acad Dermatol (1994) 0.85
Sebaceous adenoma in a patient with acquired immunodeficiency syndrome. Arch Dermatol (1988) 0.82
Interaction between cyclosporin and rifampicin. Lancet (1984) 0.81
Pemphigus foliaceus induced by psoralen-UV-A. Arch Dermatol (1998) 0.81
Pancytopenia induced by the interaction between methotrexate and trimethoprim-sulfamethoxazole. J Am Acad Dermatol (1987) 0.81
Laser skin resurfacing. Arch Dermatol (1996) 0.81
The treatment of orthostatic hypotension with dihydroxyphenylserine. Clin Neuropharmacol (1991) 0.81
Lichenoid dermatoses and related disorders. II. Lichen nitidus, lichen sclerosus et atrophicus, benign lichenoid keratoses, lichen aureus, pityriasis lichenoides, and keratosis lichenoides chronica. J Am Acad Dermatol (1990) 0.81
The use of lasers for decorative tattoo removal. Skin Therapy Lett (2006) 0.81
Evaluation of a silicone occlusive dressing after laser skin resurfacing. Arch Dermatol (2001) 0.81
Treatment of acne scarring. Skin Therapy Lett (2006) 0.80
Transfer function analysis of respiratory sinus arrhythmia: a measure of autonomic function in diabetic neuropathy. Muscle Nerve (1995) 0.80
A clinical overview of hair removal using lasers and light sources. Dermatol Clin (1999) 0.79
Visible action spectrum for melanin-specific selective photothermolysis. Lasers Surg Med (1989) 0.79
Laser treatment of tattoos: a prospective, paired, comparison study of the Q-switched Nd:YAG (1064 nm), frequency-doubled Q-switched Nd:YAG (532 nm), and Q-switched ruby lasers. J Am Acad Dermatol (1997) 0.77
The use of lasers in the pediatric population. Skin Therapy Lett (2005) 0.77
Nonablative laser and light therapy: an approach to patient and device selection. Skin Therapy Lett (2003) 0.77
Lasers in dermatology--1993. Arch Dermatol (1993) 0.76
Pulsed dye laser-resistant port-wine stains. Arch Dermatol (1996) 0.76
Kaposi's sarcoma and Mycobacterium avium-intracellulare with cellulitis in patient with acquired immunodeficiency syndrome. J Am Acad Dermatol (1989) 0.76
Recent therapeutic advances in dermatology. JAMA (2000) 0.75
Herpes simplex. Semin Neurol (1992) 0.75
Cutaneous manifestations of human immunodeficiency virus infection. Semin Neurol (1992) 0.75
Ecthymalike lesions on the leg of an immunocompromised patient. Primary cutaneous mucormycosis. Arch Dermatol (1995) 0.75
Severe hemorrhage from a 4 mm punch biopsy site in a hemophilia patient with acquired immunodeficiency syndrome. J Am Acad Dermatol (1989) 0.75
Eczematous plaques in a patient with liver failure. Fat-soluble vitamin K hypersensitivity. Arch Dermatol (1992) 0.75
Use of cutaneous lasers and light sources: appropriate training and delegation. Skin Therapy Lett (2007) 0.75
Images in clinical medicine. Basal-cell carcinoma. N Engl J Med (1993) 0.75
Lasers for vascular lesions. Dermatol Nurs (1999) 0.75
Dermatology. JAMA (1989) 0.75
Tumorous nodules on the lower extremities. Systemic mastocytosis. Arch Dermatol (1991) 0.75
Dermatology. JAMA (1990) 0.75
Keratinocyte protein expression in rapidly regenerating epidermis following laser-induced thermal injury. Lasers Surg Med (1989) 0.75
Lichen planus localized to the nails. J Cutan Med Surg (1998) 0.75
Autonomic neurodermatology (Part I): Erythromelalgia, reflex sympathetic dystrophy, and livedo reticularis. Semin Neurol (1992) 0.75
Are all 585 nm pulsed dye lasers equivalent? A prospective, comparative, photometric, and histologic study. J Am Acad Dermatol (1996) 0.75
Comparison of the 595 nm long-pulse (1.5 msec) and ultralong-pulse (4 msec) lasers in the treatment of leg veins. Dermatol Surg (1999) 0.75
Linear porokeratosis of Mibelli and DSAP. Clin Exp Dermatol (1986) 0.75
Immunohistological comparison of granulated cell proteins in induced immediate urticarial dermographism and delayed pressure urticaria lesions. Br J Dermatol (1995) 0.75
CO2 laser resurfacing: why all the fuss? Plast Reconstr Surg (1996) 0.75
Treatment of photoaging with topical aminolevulinic acid and light. Skin Therapy Lett (2005) 0.75
Lichenoid dermatoses and related disorders. I. Lichen planus and lichenoid drug-induced eruptions. J Am Acad Dermatol (1990) 0.75
Malignant pyoderma: a manifestation of Wegener's granulomatosis? J Am Acad Dermatol (1986) 0.75
Recurrent exacerbation of acne by granulocyte colony-stimulating factor administration. J Am Acad Dermatol (1996) 0.75
Successful treatment of eruptive pyoderma gangrenosum with intravenous vancomycin and mezlocillin. Br J Dermatol (1990) 0.75
A reaction to a red lip cosmetic tattoo. J Am Acad Dermatol (1998) 0.75
Spontaneous bullae over laser resurfaced skin. J Am Acad Dermatol (2000) 0.75
[Lasers and aesthetic dermatology]. Hautarzt (2003) 0.75
Advances in cutaneous aesthetic surgery. JAMA (1998) 0.75
Aesthetic surgery: coming of age. Lancet (2000) 0.75
The treatment of autonomic dysfunction. J Clin Neurophysiol (1993) 0.75
Lasers. J Am Acad Dermatol (1995) 0.75
Psoralens. New formulation! Better formulation? Arch Dermatol (1986) 0.75